AAP COVID-19 Vaccines in Infants, Children, and Adolescents Guideline Summary - Guideline Central
Summary of Recommendations
Document Overview

COVID-19 Vaccines in Infants, Children, and Adolescents

American Academy of Pediatrics


Publication Date: Aug 19, 2025

Page Last Updated: Jul 8, 2026



Document Overview

Document Title
COVID-19 Vaccines in Infants, Children, and Adolescents
Authoring Society

American Academy of Pediatrics

Document Publication Date
Aug 19, 2025
Page Last Reviewed/Updated
Jul 8, 2026
Document Type
Consensus Statement
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
publications.aap.org/pediatrics/article/doi/10.1542/peds.2025-073924/203222/Recommendations-for-COVID-19-Vaccines-in-Infants
Source Citation

American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents: Policy Statement. Pediatrics. 2025; doi: 10.1542/peds.2025-073924


Document Scope, Criteria, and Use Cases

Document Objectives

This policy statement updates the recommendations of the American Academy of Pediatrics (AAP) for the use of coronavirus disease 2019 (COVID-19) vaccines in the prevention of severe COVID-19 in children. These COVID-19 vaccine recommendations may change in future seasons or as additional variants emerge. These recommendations for the use of 2025-2026 COVID-19 vaccine are contingent upon the approval by the US Food and Drug Administration of updated COVID-19 vaccine products. COVID-19 continues to be a cause of hospitalization and death in the pediatric population. COVID-19 vaccines are safe and effective in protecting individuals and populations against serious outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, including post-acute sequelae of SARS-CoV-2 infection (PASC) and multisystem inflammatory syndrome in children (MIS-C).

Scope
Management, Prevention
Diseases/Conditions (MeSH)

D000086382 - COVID-19

D000086663 - COVID-19 Vaccines

Keywords
COVID-19 in children, COVID-19 vaccines, covid-19
Inclusion Criteria
Male, Female, Adolescent, Child, Infant
Health Care Settings
Ambulatory, Childcare Center, School
Intended Users
Community Pharmacist, Health-Systems Pharmacist, Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Number of Source Documents
18
Includes peer/external review process?
Yes
Includes public comment process?
No
Methodologist involvement?
No
Patient involvement?
No
Includes multi-disciplinary group?
Yes
Includes systematic review?
No
Grades quality of strength of evidence?
No
Grades quality of strength of recommendation?
No
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.